Ceres Pharma is a young, dynamic, and fast growing Belgian pharmaceutical company founded by the investment company Alychlo and CEO Mario Debel. It is Ceres Pharma's ambition to grow the company by developing its own portfolio, through distributions and acquisitions. Ceres Pharma is active in the development, production and distribution of drugs, medical devices, biocides, cosmetics, high-quality food supplements and pharmaceutical preparations in the Benelux and in Central and Eastern Europe.